BRAKE Trademark

Trademark Overview

On Tuesday, April 7, 2015, a trademark application was filed for BRAKE with the United States Patent and Trademark Office. The USPTO has given the BRAKE trademark a serial number of 86589179. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 24, 2019. This trademark is owned by Therasyn Pharmaceuticals, Inc.. The BRAKE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Antibacterial pharmaceuticals; anti-infective pharmaceuticals; anticancer pharmaceuticals; and antiviral pharmaceuticals; pharmaceuticals for use in connection with the treatment of diabetes, sepsis, and gastrointestinal diseases

Research and development services and consulting related thereto in the fields of antibacterial pharmaceuticals, anti-infective pharmaceuticals, anticancer pharmaceuticals, antiviral pharmaceuticals; research and development services and consulting related thereto regarding treating diabetes, sepsis, and gastrointestinal diseases
brake

General Information

Serial Number86589179
Word MarkBRAKE
Filing DateTuesday, April 7, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 24, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2016

Trademark Statements

Goods and ServicesAntibacterial pharmaceuticals; anti-infective pharmaceuticals; anticancer pharmaceuticals; and antiviral pharmaceuticals; pharmaceuticals for use in connection with the treatment of diabetes, sepsis, and gastrointestinal diseases
Goods and ServicesResearch and development services and consulting related thereto in the fields of antibacterial pharmaceuticals, anti-infective pharmaceuticals, anticancer pharmaceuticals, antiviral pharmaceuticals; research and development services and consulting related thereto regarding treating diabetes, sepsis, and gastrointestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVOLANT HOLDINGS GMBH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFEUSISBERG 8835
CH
Party NameVOLANT HOLDINGS GMBH
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressFEUSISBERG 8835
CH
Party NameTherasyn Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAmherst, NY 14226

Trademark Events

Event DateEvent Description
Monday, June 24, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 24, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 7, 2018EXTENSION 5 GRANTED
Thursday, November 1, 2018EXTENSION 5 FILED
Wednesday, November 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2018TEAS EXTENSION RECEIVED
Thursday, May 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 1, 2018EXTENSION 4 GRANTED
Tuesday, May 1, 2018EXTENSION 4 FILED
Tuesday, May 1, 2018TEAS EXTENSION RECEIVED
Wednesday, September 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2017EXTENSION 3 GRANTED
Monday, September 18, 2017EXTENSION 3 FILED
Monday, September 18, 2017TEAS EXTENSION RECEIVED
Saturday, April 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2017EXTENSION 2 GRANTED
Thursday, April 27, 2017EXTENSION 2 FILED
Thursday, April 27, 2017TEAS EXTENSION RECEIVED
Friday, November 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 23, 2016EXTENSION 1 GRANTED
Wednesday, November 23, 2016EXTENSION 1 FILED
Wednesday, November 23, 2016TEAS EXTENSION RECEIVED
Tuesday, May 24, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 17, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 10, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 10, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 10, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 30, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 17, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 17, 2015NON-FINAL ACTION E-MAILED
Friday, July 17, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Wednesday, April 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 10, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

brake pharmaceuticals development research diseases services consulting thereto related antibacterial gastrointestinal